A recent mainstream news article on noninvasive prenatal screening for rare genetic disorders has led to many questions and provides an opportunity for education and dialogue. This timely event will provide an introduction to Non-invasive Prenatal Testing (NIPT) screening, along with a detailed conversation regarding how the technology is currently deployed, how patients can benefit, and how screening tests differ from diagnostic tests.
Moderator - Jill Murrell, PhD, Director, Division of Genomic Diagnostics, The Children’s Hospital of Philadelphia, and Chair of the AMP Patient Engagement Subcommittee
Panelists - Ellen Matloff, MS, CGC, President and CEO, My Gene Counsel
Robert Nussbaum, MD, FACMG, CMO, Invitae
Kathryn G. Schubert, MPP, CAE, President and CEO, Society for Women’s Health Research